STOCK TITAN

ZimVie to Report Second Quarter 2022 Financial Results on August 10, 2022

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

ZimVie Inc. (Nasdaq: ZIMV), a leader in dental and spine markets, will report its financial results for Q2 2022 after market close on August 10, 2022. An audio webcast will follow at 4:30 p.m. ET, allowing investors to gain insights into the company’s performance post-spin-off from Zimmer Biomet. ZimVie focuses on a comprehensive product portfolio for spine and dental solutions, serving over 70 countries.

Loading...
Loading translation...
Argus Session date unavailable
-0.96% session move Open Argus
Details

News Market Reaction – ZIMV

The recorded move for ZIMV in the trading session of this news was -0.96%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WESTMINSTER, Colo., July 20, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 10, 2022. Company management will host a corresponding audio webcast beginning at 4:30 p.m. Eastern Time.

Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A replay of the webcast will be available at https://investor.zimvie.com/.

About ZimVie

ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. In March 2022 the company became an independent, publicly traded spin-off of the dental and spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence. For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.

Media Contact Information:

ZimVie
Laura Driscoll • Laura.Driscoll@ZimVie.com
(774) 284-1606

Investor Contact Information:

Gilmartin Group LLC
Marissa Bych • Marissa@Gilmartinir.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will ZimVie report its financial results for Q2 2022?

ZimVie will report its financial results for Q2 2022 after market close on August 10, 2022.

What time is the ZimVie Q2 2022 earnings call?

The ZimVie Q2 2022 earnings call will take place at 4:30 p.m. ET.

How can I listen to the ZimVie earnings call?

You can listen to the ZimVie earnings call by registering for the audio webcast via their investor relations website.

What is ZimVie’s focus in the life sciences market?

ZimVie focuses on developing, manufacturing, and delivering solutions for dental and spine markets.

Keep reading